Royal Bank of Canada
SBRA icon

Royal Bank of Canada’s Sabra Healthcare REIT SBRA Stock Holding History

Royal Bank of Canada’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Buy
107,843
+373
+0.3% +$7.35K ﹤0.01% 3066
2025
Q4 		$2.04M Sell
107,470
-427,276
-80% -$7.92M ﹤0.01% 3130
2025
Q3 		$9.97M Sell
534,746
-14,650
-3% -$274K ﹤0.01% 2160
2025
Q2 		$10.1M Buy
549,396
+22,572
+4% +$401K ﹤0.01% 2030
2025
Q1 		$9.2M Sell
526,824
-3,303
-0.6% -$55.7K ﹤0.01% 1801
2024
Q4 		$9.18M Sell
530,127
-174,586
-25% -$3.19M ﹤0.01% 1853
2024
Q3 		$13.1M Buy
704,713
+597,643
+558% +$10.1M ﹤0.01% 1618
2024
Q2 		$1.65M Sell
107,070
-7,902
-7% -$113K ﹤0.01% 3050
2024
Q1 		$1.7M Sell
114,972
-67,628
-37% -$936K ﹤0.01% 3054
2023
Q4 		$2.61M Buy
182,600
+95,344
+109% +$1.35M ﹤0.01% 2827
2023
Q3 		$1.22M Buy
87,256
+12,618
+17% +$161K ﹤0.01% 3281
2023
Q2 		$878K Sell
74,638
-27,859
-27% -$317K ﹤0.01% 3478
2023
Q1 		$1.18M Buy
102,497
+2,840
+3% +$35.1K ﹤0.01% 3222
2022
Q4 		$1.24M Buy
99,657
+60,721
+156% +$774K ﹤0.01% 3320
2022
Q3 		$510K Sell
38,936
-138,205
-78% -$2.04M ﹤0.01% 4026
2022
Q2 		$2.47M Buy
177,141
+35,656
+25% +$477K ﹤0.01% 2687
2022
Q1 		$2.11M Sell
141,485
-35,001
-20% -$479K ﹤0.01% 3005
2021
Q4 		$2.39M Buy
176,486
+58,113
+49% +$822K ﹤0.01% 2997
2021
Q3 		$1.74M Buy
118,373
+54,881
+86% +$927K ﹤0.01% 3184
2021
Q2 		$1.16M Buy
63,492
+8,480
+15% +$151K ﹤0.01% 3528
2021
Q1 		$955K Buy
55,012
+10,795
+24% +$190K ﹤0.01% 3633
2020
Q4 		$769K Buy
44,217
+21,116
+91% +$337K ﹤0.01% 3746
2020
Q3 		$317K Sell
23,101
-20,766
-47% -$305K ﹤0.01% 4222
2020
Q2 		$633K Buy
43,867
+9,705
+28% +$128K ﹤0.01% 3575
2020
Q1 		$373K Sell
34,162
-30,157
-47% -$556K ﹤0.01% 3868
2019
Q4 		$1.37M Sell
64,319
-11,284
-15% -$253K ﹤0.01% 3197
2019
Q3 		$1.74M Buy
75,603
+37,618
+99% +$802K ﹤0.01% 2871
2019
Q2 		$748K Buy
37,985
+2,860
+8% +$55.7K ﹤0.01% 3557
2019
Q1 		$683K Sell
35,125
-122,962
-78% -$2.33M ﹤0.01% 3498
2018
Q4 		$2.61M Sell
158,087
-124,775
-44% -$2.51M ﹤0.01% 2456
2018
Q3 		$6.54M Buy
282,862
+99,044
+54% +$2.24M ﹤0.01% 1918
2018
Q2 		$4M Buy
183,818
+17,457
+10% +$341K ﹤0.01% 2181
2018
Q1 		$2.94M Buy
166,361
+21,434
+15% +$378K ﹤0.01% 2389
2017
Q4 		$2.72M Sell
144,927
-36,137
-20% -$719K ﹤0.01% 2511
2017
Q3 		$3.97M Buy
181,064
+169,157
+1,421% +$3.82M ﹤0.01% 2155
2017
Q2 		$288K Sell
11,907
-1,559
-12% -$39.6K ﹤0.01% 4097
2017
Q1 		$377K Sell
13,466
-5,310
-28% -$139K ﹤0.01% 3866
2016
Q4 		$459K Buy
18,776
+2,223
+13% +$51K ﹤0.01% 3829
2016
Q3 		$417K Sell
16,553
-30,688
-65% -$735K ﹤0.01% 3863
2016
Q2 		$976K Sell
47,241
-2,693
-5% -$56.1K ﹤0.01% 3129
2016
Q1 		$1M Buy
49,934
+25,612
+105% +$491K ﹤0.01% 3051
2015
Q4 		$492K Sell
24,322
-19,091
-44% -$402K ﹤0.01% 3790
2015
Q3 		$1.01M Buy
43,413
+13,758
+46% +$351K ﹤0.01% 2854
2015
Q2 		$764K Sell
29,655
-11,741
-28% -$333K ﹤0.01% 3170
2015
Q1 		$1.37M Buy
41,396
+7,284
+21% +$236K ﹤0.01% 2601
2014
Q4 		$1.04M Buy
34,112
+4,716
+16% +$130K ﹤0.01% 2890
2014
Q3 		$715K Buy
29,396
+24,411
+490% +$677K ﹤0.01% 3127
2014
Q2 		$143K Buy
4,985
+1,800
+57% +$52.3K ﹤0.01% 4365
2014
Q1 		$89K Sell
3,185
-8,585
-73% -$236K ﹤0.01% 4605
2013
Q4 		$307K Sell
11,770
-2,578
-18% -$66.5K ﹤0.01% 3815
2013
Q3 		$330K Buy
14,348
+8,528
+147% +$210K ﹤0.01% 3720
2013
Q2 		$152K Buy
+5,820
New +$168K ﹤0.01% 4060

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada's SBRA Position: Q1 2026 in Review

Royal Bank of Canada increased its Sabra Healthcare REIT (SBRA) stake by 0.35% in Q1 2026, buying an estimated $7.35K and bringing the position to 107,843 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3066.

Royal Bank of Canada first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1M in Q3 2024. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Royal Bank of Canada held 107,843 shares of Sabra Healthcare REIT worth $2.08M as of Q1 2026.
  • Royal Bank of Canada bought 373 Sabra Healthcare REIT shares in Q1 2026, an estimated $7.35K.
  • Sabra Healthcare REIT made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3066 holding.
  • Royal Bank of Canada first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Sabra Healthcare REIT position peaked at $13.1M in Q3 2024.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.